News

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
A decision is expected in the fourth quarter of 2025.
Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...
A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...